CompoAtlas

FitMiss Balance

Originaltext auf Französisch.

In Kanada zugelassenes natürliches Gesundheitsprodukt

Falls dieses Produkt in Frankreich verkauft würde

Eine Tagesmenge wird nur bei ausdrücklicher oraler Dosierung für Erwachsene berechnet, die pro Tag und in einer zur Produktform passenden festen Einheit angegeben ist. Mehrdeutige Einheiten, Flüssigkeiten, Pulver und pädiatrische Dosen werden nicht hochgerechnet. Eine nicht berechnete Menge wird nicht mit Dosisgrenzwerten verglichen. Diese Analyse stellt weder eine Verkaufszulassung in Frankreich noch eine Sicherheits- oder Wirksamkeitsbewertung dar.

Zusammensetzung

Arzneilicher Inhaltsstoff und QuelleJe Dosiseinheit laut QuelleTäglich höchstens, Erwachsene
Diastase du malt

Quelle : Aspergillus flavus var. oryzae - En entier

0,005 Unités de degrés de pouvoir diastatique du FCCNicht berechnet
Diastase du malt

Quelle : Aspergillus flavus var. oryzae - En entier

0,044 mgNicht berechnet
Fragaria x ananassa

Quelle : Fragaria x ananassa - fruit

2,583 mgNicht berechnet
Huile de poisson

Quelle : Engraulidae - en entier

Stärke : 50 mcg Eicosapentaenoic acid

0,518 mgNicht berechnet
Huile de poisson

Quelle : Engraulidae - en entier

Stärke : 35 mcg Docosahexaenoic acid

Nicht angegebenNicht berechnet
Huile de poisson

Quelle : Clupeidae - en entier

Stärke : 50 mcg Eicosapentaenoic acid

0,518 mgNicht berechnet
Huile de poisson

Quelle : Clupeidae - en entier

Stärke : 35 mcg Docosahexaenoic acid

Nicht angegebenNicht berechnet
Bromélaïne de fruit

Quelle : Ananas comosus var. comosus - fruit

0,072 FCC PUNicht berechnet
Bromélaïne de fruit

Quelle : Bromélaïne de fruit

0,072 FCC PUNicht berechnet
Bromélaïne de fruit

Quelle : Ananas comosus var. comosus - fruit

0,004 mgNicht berechnet
Bromélaïne de fruit

Quelle : Bromélaïne de fruit

0,004 mgNicht berechnet
bêta-D-fructofuranoside fructohydrolase

Quelle : Saccharomyces cerevisiae - en entier

0,0003 FCC SUNicht berechnet
bêta-D-fructofuranoside fructohydrolase

Quelle : Invertase

0,0003 FCC SUNicht berechnet
bêta-D-fructofuranoside fructohydrolase

Quelle : Saccharomyces cerevisiae - en entier

0,004 mgNicht berechnet
bêta-D-fructofuranoside fructohydrolase

Quelle : Invertase

0,004 mgNicht berechnet
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one

Quelle : Quercétine

2,453 mgNicht berechnet
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one

Quelle : Styphnolobium japonicum - Bourgeon floral

2,453 mgNicht berechnet
Protéase fongique

Quelle : Protéase fongique

0,029 FCC SAPUNicht berechnet
Protéase fongique

Quelle : Aspergillus niger - En entier

0,029 FCC SAPUNicht berechnet
Potassium

Quelle : Chlorure de potassium

6,33 mg18.990 µg
Arthrospira platensis

Quelle : Arthrospira platensis - en entier

15,541 mgNicht berechnet
Serenoa repens

Quelle : Serenoa repens - fruit

2,583 mgNicht berechnet
3-Pyridinecarboxamide

Quelle : Niacinamide

3,33 mgNicht berechnet
4-alpha-D-Glucane glucanohydrolase

Quelle : Aspergillus flavus var. oryzae - En entier

26,049 FCC DUNicht berechnet
4-alpha-D-Glucane glucanohydrolase

Quelle : Alpha-amylase

26,049 FCC DUNicht berechnet
4-alpha-D-Glucane glucanohydrolase

Quelle : Aspergillus flavus var. oryzae - En entier

0,914 mgNicht berechnet
4-alpha-D-Glucane glucanohydrolase

Quelle : Alpha-amylase

0,914 mgNicht berechnet
Serratiopeptidase

Quelle : Serratia - Cellule entière

0,007 SPUNicht berechnet
Serratiopeptidase

Quelle : Serratia - Cellule entière

0,014 mgNicht berechnet
Fer

Quelle : Sulfate ferreux

6 mg18.000 µg
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Quelle : Tagetes erecta - Oléorésine (herbe en fleurs)

0,155 mgNicht berechnet
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Quelle : Lutéine

0,155 mgNicht berechnet
Vitamine D

Quelle : Cholécalciférol

1,66 mcg4,98 µg
Vitamine D

Quelle : Cholécalciférol

66,66 UI4,9995 µg
Molybdène

Quelle : Molybdate de sodium

1,56 mcg4,68 µg
Punica granatum

Quelle : Punica granatum, Fruit

5,18 mgNicht berechnet
Linum usitatissimum

Quelle : Linum usitatissimum - Graine

123,544 mgNicht berechnet
Protéase fongique

Quelle : Aspergillus flavus var. oryzae - En entier

0,063 FCC HUTNicht berechnet
Protéase fongique

Quelle : Protéase fongique

0,063 FCC HUTNicht berechnet
Protéase fongique

Quelle : Aspergillus flavus var. oryzae - En entier

0,638 mgNicht berechnet
Protéase fongique

Quelle : Protéase fongique

0,638 mgNicht berechnet
Myo-Inositol

Quelle : Inositol

0,99 mgNicht berechnet
Bêta-carotène tout trans

Quelle : bêta-carotène

500 mcgNicht berechnet
Vitamine C

Quelle : Vitamine C

39,33 mg117.990 µg
Vitamine E

Quelle : Acétate de dl-alpha tocophéryle

1,5 mg ATNicht berechnet
Vitamine E

Quelle : Acétate de dl-alpha tocophéryle

3,33 UINicht berechnet
Thiamine

Quelle : Mononitrate de thiamine

2,66 mg7.980 µg
Riboflavine

Quelle : Riboflavine

2,66 mg7.980 µg
Vitamine B6

Quelle : Chlorhydrate de pyridoxine

2,66 mg7.980 µg
Vitamine B12

Quelle : Méthylcobalamine

21,66 mcg64,98 µg
Biotine

Quelle : Biotine

50 mcg150 µg
Acide d-pantothénique

Quelle : D-Pantothénate de calcium

5,33 mgNicht berechnet
Vitamin K2

Quelle : Vitamin K2

13,33 mcg39,99 µg
Folate

Quelle : Folate

21,66 mcgNicht berechnet
Boron

Quelle : Citrate de bore

78,33 mcgNicht berechnet
Calcium

Quelle : Lactate gluconate de calcium

8 mg24.000 µg
Cuivre

Quelle : Gluconate cuivrique

10,66 mcg31,98 µg
Chrome

Quelle : Polynicotinate de chrome (III)

10,66 mcg31,98 µg
Magnésium

Quelle : Citrate de magnésium

15,66 mg46.980 µg
Manganèse

Quelle : Citrate de manganèse (II)

105 mcg315 µg
Zinc

Quelle : Oxyde de zinc

1,05 mg3.150 µg
Sélénium

Quelle : Sélénométhionine

10,66 mcg31,98 µg
Laminaria digitata

Quelle : Laminaria digitata - En entier

Stärke : 0,075 % Iodine

18,833 mgNicht berechnet
papaïne

Quelle : Carica papaya - fruit

21,77 FCC PUNicht berechnet
papaïne

Quelle : Papain

21,77 FCC PUNicht berechnet
papaïne

Quelle : Carica papaya - fruit

0,11 mgNicht berechnet
papaïne

Quelle : Papain

0,11 mgNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Citrus aurantiifolia - Pelure (fruit)

3,878 mgNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Bioflavonoïdes d'agrumes

3,878 mgNicht berechnet
Bioflavonoïdes d'agrumes

Quelle : Citrus limon - Pelure (fruit)

3,878 mgNicht berechnet
Arctostaphylos uva-ursi

Quelle : Arctostaphylos uva-ursi - feuille

2,583 mgNicht berechnet
Acide 4-aminobenzoïque

Quelle : Acide para-aminobenzoïque

1,295 mgNicht berechnet
Chlorella vulgaris

Quelle : Chlorella vulgaris - Whole

10,36 mgNicht berechnet
Palmaria palmata

Quelle : En entier

Stärke : 0,075 % Iodine

16,667 mgNicht berechnet
Echinacea angustifolia

Quelle : Echinacea angustifolia - racine

Extraktionsverhältnis : 4:1

Trockenpflanzenäquivalent : 20,72 mg

5,18 mgNicht berechnet
1,2-Diacyl-SN-Glycero-3-Phosphocholine

Quelle : Huile de soja

2,848 mgNicht berechnet
N,N-Dimethylglycine

Quelle : Diméthylglycine

28,787 mgNicht berechnet
Protéase fongique

Quelle : Protéase fongique

0,218 mgNicht berechnet
Protéase fongique

Quelle : Aspergillus niger - En entier

0,218 mgNicht berechnet
Protéase bactérien

Quelle : Bacillus subtilis - cellule entière

2,943 FCC PCNicht berechnet
Protéase bactérien

Quelle : Protéase bactérien

2,943 FCC PCNicht berechnet
Protéase bactérien

Quelle : Bacillus subtilis - cellule entière

0,218 mgNicht berechnet
Protéase bactérien

Quelle : Protéase bactérien

0,218 mgNicht berechnet
alpha-D-Galactoside galactohydrolase

Quelle : alpha-Galactosidase

0,006525 FCC GalUNicht berechnet
alpha-D-Galactoside galactohydrolase

Quelle : Aspergillus niger - En entier

0,006525 FCC GalUNicht berechnet
alpha-D-Galactoside galactohydrolase

Quelle : alpha-Galactosidase

0,145 mgNicht berechnet
alpha-D-Galactoside galactohydrolase

Quelle : Aspergillus niger - En entier

0,145 mgNicht berechnet
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Quelle : Cellulase

0,052 FCC CUNicht berechnet
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Quelle : Trichoderma reesei - en entier

0,052 FCC CUNicht berechnet
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Quelle : Cellulase

0,13 mgNicht berechnet
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Quelle : Trichoderma reesei - en entier

0,13 mgNicht berechnet
1,3-bêta-D-xylane xylanohydrolase

Quelle : Trichoderma reesei - en entier

0,039 FCC HCUNicht berechnet
1,3-bêta-D-xylane xylanohydrolase

Quelle : Hemicellulase

0,039 FCC HCUNicht berechnet
1,3-bêta-D-xylane xylanohydrolase

Quelle : Trichoderma reesei - en entier

0,078 mgNicht berechnet
1,3-bêta-D-xylane xylanohydrolase

Quelle : Hemicellulase

0,078 mgNicht berechnet
bêta-galactosidase

Quelle : Lactase

0,058 FCC ALUNicht berechnet
bêta-galactosidase

Quelle : Aspergillus flavus var. oryzae - En entier

0,058 FCC ALUNicht berechnet
bêta-galactosidase

Quelle : Lactase

0,042 mgNicht berechnet
bêta-galactosidase

Quelle : Aspergillus flavus var. oryzae - En entier

0,042 mgNicht berechnet
Triacylglycérol lipase

Quelle : Aspergillus niger - En entier

0,325 FCC LUNicht berechnet
Triacylglycérol lipase

Quelle : Triacylglycerol lipase

0,325 FCC LUNicht berechnet
Triacylglycérol lipase

Quelle : Aspergillus niger - En entier

0,27 mgNicht berechnet
Triacylglycérol lipase

Quelle : Triacylglycerol lipase

0,27 mgNicht berechnet
1,4-alpha-D-Glucane glucohydrolase

Quelle : Glucan 1,4-alpha-glucosidase

0,001 FCC GalUNicht berechnet
1,4-alpha-D-Glucane glucohydrolase

Quelle : Aspergillus niger - En entier

0,001 FCC GalUNicht berechnet
1,4-alpha-D-Glucane glucohydrolase

Quelle : Glucan 1,4-alpha-glucosidase

0,073 mgNicht berechnet
1,4-alpha-D-Glucane glucohydrolase

Quelle : Aspergillus niger - En entier

0,073 mgNicht berechnet
2-hydroxy-N,N,N-triméthyléthanaminium

Quelle : Bitartrate de choline

2,583 mgNicht berechnet
Saccharomyces boulardii

Quelle : En entier

3 Milliards d'UFCNicht berechnet
Saccharomyces boulardii

Quelle : En entier

20,833 mgNicht berechnet
Trans-resvératrol

Quelle : Reynoutria Japonica - racine

3,333 mgNicht berechnet
Trans-resvératrol

Quelle : Resvératrol

3,333 mgNicht berechnet
Curcuma longa

Quelle : Curcuma longa - Racine

Extraktionsverhältnis : 10:1

Trockenpflanzenäquivalent : 46,57 mg

4,657 mgNicht berechnet
Sel interne d'hydroxyde de (carboxyméthyl)triméthylammonium

Quelle : Chlorhydrate de bétaine

0,518 mgNicht berechnet

Nicht arzneiliche Inhaltsstoffe

Bleu FD&C # 1, Extrait de fruit de Vaccinium vitis-Idaea, Cerisier sauvage, FD&C Red No. 3 Aluminum Lake, Mangifera indica (Mango) Fruit Extact, Cellulose microcristalline, Daucus carota, Pomme, Lécithine de soja enrichie en phosphatidylsérine, Poudre de fruit de framboise rouge, Herbe d'orge, Dioxyde de titane, Rouge FD&C N° 40, Spinach powder, Hespéridine, Lycopène, Maltodextrine, Triglycérides à chaîne moyenne, Amidon de Zea Mays (maïs), Ribes rubrum, Poudre de Brassica oleracea italica (Brocoli), Colloidal silicon dioxide, Stéarate de magnésium, Jus de mûre déshydraté, Poudre de bulbe d'ail, Extrait de fruit de Citrum Aurantium Dulcis (Oranger), Gélatine, Astaxanthin, Carotènes mélangées

In Kanada empfohlene Dosen

BevölkerungsgruppeAlterMenge pro EinnahmeHäufigkeit
Adultes de sexe fémininNon précisée3 Capsule1 Tous les jours

In Kanada zugelassene Verwendungen

Source of vitamin A for the maintenance of good health. Provitamin A for the maintenance of good health. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Provitamin A to help maintain eyesight, skin, membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision, Provitamin A to help in the development and maintenance of night vision. Source of vitamin A to help in the development and maintenance of bones and teeth. Provitamin A to help in the development and maintenance of bones and teeth. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in wound healing. Helps in the absorption and use of calcium and phosphorus. An antioxidant for the maintenance of good health. Helps normal growth and development. Helps in the maintenance of good health. Helps to form red blood cells and helps in their proper function. Helps to prevent iron deficiency anaemia. Provides support for healthy glucose metabolism. Helps in tissue formation. Helps to maintain proper muscle function. Helps the body to metabolize carbohydrates, fats and proteins. Helps in connective tissue formation. Helps to maintain healthy skin. Helps to maintain immune function. Digestive aid. Digestive enzyme. Source of probiotics. Helps to prevent Vitamin C, thiamine, riboflavin, Vitamin B6, Vitamin B12, Biotin, and pantothenic acid deficiency. Source of antioxidants. A factor in the maintenance of good health. Provides antioxidants.

Originaltext auf Englisch.

Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.

Warnhinweise in Kanada

Known Adverse Reactions : Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. Nausea, vomiting and diarrhea have been known to occur, in which case discontinue use.

Originaltext auf Englisch.

Contra-Indications : If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment or are taking immunosupressants), do not use this product. Do not use if you are pregnant or breastfeeding.

Originaltext auf Englisch.

Cautions and Warnings : Consult a health care practitioner prior to use if you are taking prescription medications including blood thinners, digoxin, antidepressants, an anticoagulant anti-inflammatory, have an autoimmune disorder, progressive system disease such as tuberculosis, collagenosis or multiple sclerosis, have a liver disorder or develop symptoms of liver trouble (such as abdominal pain, dark urine or jaundice), have iron deficiency, diabetes, prostate cancer, gastrointestinal lesion/ulcer, gallstones, bile duct obstruction, stomach ulcers, excess stomach acid, or are having surgery. If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach, and tomato), consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. Keep out of reach of children. There is enough drug in this package to seriously harm a child. Consult a health care practitioner prior to use if you are taking sulfonamides. Consult health care practitioner prior to use if you are taking antibiotics.

Originaltext auf Englisch.

Produktdaten

Inhaber
MusclePharm Corporation
NPN oder DIN-HM
80057871
Status
Lizenz nicht aktiv
Lizenzdatum
3. Februar 2015
Überarbeitungsdatum
Nicht angegeben
Form
Capsule
Verabreichungsweg
Orale
Art des Antrags
Non traditionnelle

Quelle

Amtlicher Health-Canada-Eintrag, Zulassung 80057871

Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Originaltext auf Englisch.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Originaltext auf Französisch.

Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.

Offizielle Warnhinweise (Health Canada)

Health Canada veröffentlicht Warnhinweise zu diesen Zutaten:

  • Huile de poisson
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    FISH OIL

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: Pain of rheumatoid arthritis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Anwendungsbedingung: Healthy mood balance.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.

    Monografie von Health Canada vom 25. September 2026

  • Serenoa repens
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    SAW PALMETTO – SERENOA REPENS

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All subpopulations.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Anwendungsbedingung: Adult males only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).

    Von Health Canada zitierte Quellen (2)
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
    • USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.

    Anwendungsbedingung: Adult females only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).

    Von Health Canada zitierte Quellen (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Gegenanzeigen

    Anwendungsbedingung: Adult females only.

    Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).

    Von Health Canada zitierte Quellen (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Monografie von Health Canada vom 19. Dezember 2025

  • Serratiopeptidase
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    SERRAPEPTASE

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gastrointestinal lesions/ulcers, a kidney or liver disorder, or are having surgery (Bhagat et al. 2013; Chopra et al. 2009; Al- Khateeb and Nusair 2008; Mazzone et al. 1990).

    Von Health Canada zitierte Quellen (4)
    • Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematische Übersicht
    • Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomisierte Studie
    • Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomisierte Studie
    • Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomisierte Studie

    1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or anti-inflammatory medications (Bhagat et al. 2013; Chopra et al. 2009; Al-Khateeb and Nusair 2008; Mazzone et al. 1990).

    Von Health Canada zitierte Quellen (4)
    • Al-Khateeb TH and Nusair Y. Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. International Journal of Oral Maxillofacial Surgery 2008;37:264-268. PubMed Randomisierte Studie
    • Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematische Übersicht
    • Chopra D, Rehan HS, Mehra P, et al. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. International Journal of Oral Maxillofacial Surgery 2009;38:350-355. PubMed Randomisierte Studie
    • Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388. PubMed Randomisierte Studie

    Bekannte Nebenwirkungen

    Stop use if rash, difficulty breathing, hypersensitivity and/or severe allergy occur (Bhagat et al. 2013; Balagi 2007).

    Von Health Canada zitierte Quellen (1)
    • Bhagat S, Agarwal M and Roy V. Serratiopeptidase : A systemic review of the existing evidence. International Journal of Surgery 2013;11(3):209-217 PubMed Systematische Übersicht

    1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).

    Monografie von Health Canada vom 25. Juli 2025

  • Vitamine D
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    VITAMIN D (>1,000 - 2,500 IU)

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    Von Health Canada zitierte Quellen (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    Von Health Canada zitierte Quellen (3)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
    • DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Gilt für Produkte: containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Gilt für Produkte: providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Gegenanzeigen

    Anwendungsbedingung: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    Von Health Canada zitierte Quellen (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Gilt für Produkte: containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Bekannte Nebenwirkungen

    Anwendungsbedingung: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    Von Health Canada zitierte Quellen (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Gilt für Produkte: providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Monografie von Health Canada vom 26. Juni 2026

  • Punica granatum
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen
  • Linum usitatissimum
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    FLAXSEED - LINUM USITATISSIMUM

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Gilt für Produkte: providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    Von Health Canada zitierte Quellen (1)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    Von Health Canada zitierte Quellen (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Anwendungsbedingung: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    Von Health Canada zitierte Quellen (2)
    • Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
    • Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.

    Gegenanzeigen

    Gilt für Produkte: providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    Von Health Canada zitierte Quellen (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    Von Health Canada zitierte Quellen (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
    • Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.

    Bekannte Nebenwirkungen

    Anwendungsbedingung: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    Von Health Canada zitierte Quellen (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.

    Monografie von Health Canada vom 26. Juli 2024

  • Arctostaphylos uva-ursi
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    Bearberry - Arctostaphylos Uva-Ursi

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Gilt für Produkte: providing 60 milligrams or more of dried leaves and/or products providing 20 milligrams or more of Arbutin, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder, fever, painful urination (dysuria), spasms, or blood in urine (EMA 2018; Duke 2002; Newall 1996).

    Von Health Canada zitierte Quellen (2)
    • EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
    • Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A guide for health-care professionals. London (GB): The Pharmaceutical Press; 1996.

    1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).

    Gegenanzeigen

    Do not use if you are pregnant or breastfeeding (EMA 2018; Brinker 2010; ESCOP 2003; WHO 2002; Blumenthal 2000; Mills and Bone 2000; Bradley 1992).

    Von Health Canada zitierte Quellen (8)
    • Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • Bradley PR, editor. British Herbal Compendium Volume 1: A Handbook of Scientific Information on Widely Used Plant Drugs - Companion Volume 1 of the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 1992.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
    • ESCOP 2003: European Scientific Cooperative of Phytotherapy. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition completely revised and expanded. Exeter (GB): European Scientific Cooperative on Phytotheraphy; 2003.
    • Mills S, Bone K. Principles and Practice of Phytotherapy, Modern Herbal Medicine. Edinburg (GB): Churchill LYes Soivingston; 2000.
    • WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 3. Geneva (CH): World Health Organization; 2002.
    • OMS 2002: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 3. Genève (CH): Organisation mondiale de la santé; 2002.

    Monografie von Health Canada vom 30. Januar 2026

  • Chlorella vulgaris
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    CHLORELLA - CHLORELLA VULGARIS

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Gilt für Produkte: providing 250 mg or more of chlorella per day or 6 µg or more vitamin K per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Ohkawa et al. 1995; NNHPD Multi-vitamin/mineral supplements monograph).

    Von Health Canada zitierte Quellen (1)
    • Ohkawa S, Yoneda Y, Ohsumi Y, Tabuchi M. Warfarin therapy and chlorella. Rinsho Shinkeigaku 1995;35(7):806-807. PubMed Fallbericht

    Gilt für Produkte: containing chlorella enriched with selenium and providing more than 70 µg of selenium per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of non-melanoma skin cancer (Doucha et al. 2009; NNHPD Multi-vitamin/mineral supplements monograph).

    Von Health Canada zitierte Quellen (1)
    • Doucha J, Livansky K, Kotrbacek V, Zachleder V. Production of Chlorella biomass enriched by selenium and its use in animal nutrition: a review. Applied Microbiology and Biotechnology 2009;83(6):1001-1008. PubMed Übersichtsartikel

    Bekannte Nebenwirkungen

    Stop use if hypersensitivity/allergy occurs (Tiberg et al. 1995).

    Von Health Canada zitierte Quellen (1)
    • Tiberg E, Dreborg S, Bjorksten B. Allergy to green algae (Chlorella) among children. Journal of Allergy and Clinical Immunology 1995;96(2):257-259. PubMed

    Monografie von Health Canada vom 27. Juni 2025

  • Echinacea angustifolia
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    ECHINACEA- ECHINACEA ANGUSTIFOLIA

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (Gardner and McGuffin 2013; Brinker 2010).

    Von Health Canada zitierte Quellen (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).

    Von Health Canada zitierte Quellen (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Monografie von Health Canada vom 28. März 2025

  • Curcuma longa
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    TURMERIC - CURCUMA LONGA - Oral

    Art der Anwendung: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    Von Health Canada zitierte Quellen (2)
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.

    1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    Von Health Canada zitierte Quellen (6)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    Von Health Canada zitierte Quellen (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    Von Health Canada zitierte Quellen (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Anwendungsbedingung: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografie von Health Canada vom 26. September 2025

    Turmeric -CURCUMA LONGA - Topical

    Vorsichtsmaßnahmen und Warnhinweise

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Gegenanzeigen

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Monografie von Health Canada vom 28. Februar 2025

Sie betreffen die Zutat, nicht dieses Produkt oder seine Dosis. Sie ersetzen keinen ärztlichen Rat.

Das Belegdatum dieser Zutatenliste ist unbekannt.

Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.

Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.

Eingabetaste zum Analysieren, Umschalt+Eingabetaste für eine neue Zeile